Identification of TUBB2A by quantitative proteomic analysis as a novel biomarker for the prediction of distant metastatic breast cancer

[1]  Alok K. Shah,et al.  Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. , 2019, Journal of proteome research.

[2]  Dohyun Han,et al.  In-Depth, Proteomic Analysis of Nasal Secretions from Patients With Chronic Rhinosinusitis and Nasal Polyps , 2019, Allergy, asthma & immunology research.

[3]  M. Campone,et al.  iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors , 2019, Proteomics.

[4]  G. Mills,et al.  Breast cancer quantitative proteome and proteogenomic landscape , 2019, Nature Communications.

[5]  Olga T. Schubert,et al.  Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry , 2019, bioRxiv.

[6]  Junshik Hong,et al.  Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2019, Blood cells, molecules & diseases.

[7]  Martin Eisenacher,et al.  The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..

[8]  H. Ryu,et al.  Integrated Multi‐Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal‐Like Triple‐Negative Breast Cancer , 2018, Proteomics. Clinical applications.

[9]  Tamar Geiger,et al.  Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification. , 2018, Cancer research.

[10]  Hua Wang,et al.  PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis. , 2018, Oncology reports.

[11]  Ji Hye Moon,et al.  Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology* , 2018, Molecular & Cellular Proteomics.

[12]  Jin‐Young Jang,et al.  Quantitative proteomic analysis of pancreatic cyst fluid proteins associated with malignancy in intraductal papillary mucinous neoplasms , 2018, Clinical proteomics.

[13]  Dohyun Han,et al.  Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers. , 2018, Clinical biochemistry.

[14]  Dohyun Han,et al.  Molecular and functional signatures in a novel Alzheimer’s disease mouse model assessed by quantitative proteomics , 2018, Molecular Neurodegeneration.

[15]  I. Tseng,et al.  OTUD7B upregulation predicts a poor response to paclitaxel in patients with triple-negative breast cancer , 2017, Oncotarget.

[16]  A. Jemal,et al.  Breast cancer statistics, 2017, racial disparity in mortality by state , 2017, CA: a cancer journal for clinicians.

[17]  Jin‐Young Jang,et al.  Proteome characterization of human pancreatic cyst fluid from intraductal papillary mucinous neoplasm by liquid chromatography/tandem mass spectrometry. , 2017, Rapid communications in mass spectrometry : RCM.

[18]  Xiaofeng Dai,et al.  Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping , 2017, Journal of Cancer.

[19]  G. Lianos,et al.  Breast cancer in young women: an overview , 2017, Updates in Surgery.

[20]  Yongmei Yin,et al.  Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44. , 2017, American journal of translational research.

[21]  Juan Antonio Vizcaíno,et al.  The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition , 2016, Nucleic Acids Res..

[22]  Ruedi Aebersold,et al.  Mass-spectrometric exploration of proteome structure and function , 2016, Nature.

[23]  Yingying Wang,et al.  PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis , 2016, Archives of Gynecology and Obstetrics.

[24]  Matthias Mann,et al.  Plasma Proteome Profiling to Assess Human Health and Disease. , 2016, Cell systems.

[25]  L. Gatto,et al.  A draft map of the mouse pluripotent stem cell spatial proteome , 2016, Nature Communications.

[26]  Martin Eisenacher,et al.  PRIDE Inspector Toolsuite: Moving Toward a Universal Visualization Tool for Proteomics Data Standard Formats and Quality Assessment of ProteomeXchange Datasets , 2015, Molecular & Cellular Proteomics.

[27]  A. Guzman,et al.  Breast Cancer Cell Line Aggregate Morphology Does Not Predict Invasive Capacity , 2015, PloS one.

[28]  S. Gygi,et al.  Comprehensive Temporal Protein Dynamics during the Diauxic Shift in Saccharomyces cerevisiae , 2015, Molecular & Cellular Proteomics.

[29]  M. de Boer,et al.  Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? , 2015, British Journal of Cancer.

[30]  Melinda M. Mulvihill,et al.  Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity. , 2014, Chemistry & biology.

[31]  Jeffrey R. Whiteaker,et al.  Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.

[32]  Dohyun Han,et al.  Proteomic analysis of mouse astrocytes and their secretome by a combination of FASP and StageTip‐based, high pH, reversed‐phase fractionation , 2014, Proteomics.

[33]  Edward L. Huttlin,et al.  Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction , 2014, Cell.

[34]  Li Ma,et al.  α-catenin acts as a tumor suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signaling , 2014, Nature Cell Biology.

[35]  Andrew R. Jones,et al.  ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.

[36]  M. Mann,et al.  Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells , 2014, Nature Methods.

[37]  Dohyun Han,et al.  In‐depth proteomic analysis of mouse microglia using a combination of FASP and StageTip‐based, high pH, reversed‐phase fractionation , 2013, Proteomics.

[38]  K. Kelly,et al.  Metastatic biomarker discovery through proteomics. , 2012, Cancer genomics & proteomics.

[39]  L. Postovit,et al.  A Unique 3D In Vitro Cellular Invasion Assay , 2012, Journal of biomolecular screening.

[40]  Ghislain Bidaut,et al.  Interactome-transcriptome integration for predicting distant metastasis in breast cancer , 2012, Bioinform..

[41]  Martin Kircher,et al.  Deep proteome and transcriptome mapping of a human cancer cell line , 2011, Molecular systems biology.

[42]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[43]  M. Mann,et al.  Defining the transcriptome and proteome in three functionally different human cell lines , 2010, Molecular systems biology.

[44]  Matthias Mann,et al.  Proteomic Changes Resulting from Gene Copy Number Variations in Cancer Cells , 2010, PLoS genetics.

[45]  Karen Gelmon,et al.  Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  M. Mann,et al.  Decoding signalling networks by mass spectrometry-based proteomics , 2010, Nature Reviews Molecular Cell Biology.

[47]  S. Schnitt,et al.  Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy , 2010, Modern Pathology.

[48]  R. Seruca,et al.  Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells , 2010, Oncogene.

[49]  L. Holmberg,et al.  Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment , 2009, PloS one.

[50]  T. Pan,et al.  tRNA over-expression in breast cancer and functional consequences , 2009, Nucleic acids research.

[51]  Manuela Truebano,et al.  The consequences of sample pooling in proteomics: An empirical study , 2009, Electrophoresis.

[52]  M. Mlodzik,et al.  A Quest for the Mechanism Regulating Global Planar Cell Polarity of Tissues , 2022 .

[53]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[54]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[55]  A. Gown,et al.  Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  G. Kallergi,et al.  Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients , 2008, Breast Cancer Research.

[57]  Sigurd B. Angenent,et al.  On the spontaneous emergence of cell polarity , 2008, Nature.

[58]  L. Hughes,et al.  Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity , 2008, Clinical & Experimental Metastasis.

[59]  J. Luk,et al.  Association of Mortalin (HSPA9) with Liver Cancer Metastasis and Prediction for Early Tumor Recurrence* , 2008, Molecular & Cellular Proteomics.

[60]  R. Cress,et al.  Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.

[61]  H. Ishwaran,et al.  Lung metastasis genes couple breast tumor size and metastatic spread , 2007, Proceedings of the National Academy of Sciences.

[62]  T. Gilmore.  Introduction to NF-κB: players, pathways, perspectives , 2006, Oncogene.

[63]  Wei Wei,et al.  Metastatic patterns in adenocarcinoma , 2006, Cancer.

[64]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[65]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[66]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[67]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[68]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[69]  Jenny C. Chang,et al.  Survival of patients with metastatic breast carcinoma , 2003, Cancer.

[70]  Avri Ben-Ze'ev,et al.  The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.

[71]  T. Uchiyama,et al.  Molecular cloning, genomic structure, chromosomal localization, and alternative splice forms of the platelet collagen receptor glycoprotein VI. , 2000, Biochemical and biophysical research communications.

[72]  W. Vainchenker,et al.  Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. , 2000, Blood.

[73]  R. Rubens,et al.  The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.

[74]  R. Vihko,et al.  Significance of estrogen and progesterone receptors, disease‐free interval, and site of first metastasis on survival of breast cancer patients , 1985, Cancer.

[75]  J. Horton,et al.  Follow‐up of breast cancer patients , 1984, Cancer.

[76]  Rohit J. Kate,et al.  Stage-specific predictive models for breast cancer survivability , 2017, Int. J. Medical Informatics.

[77]  Tongzhang Zheng,et al.  Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. , 2011, International journal of molecular epidemiology and genetics.

[78]  N. Perkins,et al.  Integrating cell-signalling pathways with NF-κB and IKK function , 2007, Nature Reviews Molecular Cell Biology.

[79]  V. Castronovo,et al.  Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells , 2006, Breast Cancer Research and Treatment.

[80]  P. Pavasant,et al.  Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-basedin vitro assays , 2005, Breast Cancer Research and Treatment.

[81]  E. Gelmann,et al.  Differentiation state and invasiveness of human breast cancer cell lines , 2004, Breast Cancer Research and Treatment.

[82]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..